Focus Rheums| ACR Convergence 2024 Previews

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Mortality Rates Improve for Patients with Rheumatoid Arthritis

  |  Issue: October 2014  |  

She also says, though, that recent research suggests that people with RA may age at an accelerated rate compared with those without RA, adding fuel to the need for early aggressive treatment.

“The systemic inflammation that characterizes RA puts people with the disease at risk of accelerated aging and early mortality,” she says. “Early, aggressive treatment is our best means of addressing these risks.”

ADVERTISEMENT
SCROLL TO CONTINUE

Mary Beth Nierengarten is a freelance medical journalist based in St. Paul, Minn.

References

  1. Norton S, et al. Excess mortality in rheumatoid arthritis: Gains in life expectancy over 25 years. BSR. 2014; Abstract O34.
  2. Humphreys JH, Warner A, Chipping J. Mortality trends in patients with early rheumatoid arthritis over 20 years: Results from the Norfolk Arthritis Register. Arthritis Care Res (Hoboken). 2014 Sep;66(9):1296–1301.

Related Articles

    Do Bisphosphonates Reduce Cardiovascular-Related Mortality?

    It is well known that hip fractures are associated with significant morbidity and mortality: Mortality increases 15–25% in the year following a hip fracture.1–5 We know that treating osteo­porosis prevents fractures and improves patient survival. But is there a relationship beyond this? Several studies have found that bisphosphonate therapy is associated with a reduction in…

    Studies Say People with Rheumatic Disease Face Work Challenges

    EULAR 2020 e-CONGRESS—People with rheumatic diseases have more difficulty than others leading a work life, and researchers are attempting to quantify just how long they are able to remain healthy and working compared with the general population. This topic is particularly pressing because people are now expected to work for a longer and longer periods…

    Studies Highlight Risk of Damage from Lupus Treatments

    WASHINGTON, D.C.—Conference goers who braved the final day of the 2016 ACR/ARHP Annual Meeting were awarded for their stamina by learning about issues relating to the damage caused by systemic lupus erythematosus (SLE) during the session Systemic Lupus Erythematosus—Clinical Aspects and Treatment V: Damage and Morbidity. Minimizing Damage: Early Use of GC-Sparing Strategies Jayne Little,…